Furthermore, emerging evidence suggests that CDKN2A may play a role in the maintenance of glioblastoma stem cells (GSCs), a subpopulation of cells with self-renewal capacity and pluripotency that contribute to tumor initiation, growth, and therapy resistance[17]. The gene discussed is CDKN2A; the disease is neoplasm.